News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
165,042 Results
Type
Article (5629)
Company Profile (47)
Press Release (159365)
Section
Business (55007)
Career Advice (176)
Deals (10409)
Drug Delivery (11)
Drug Development (19534)
Employer Resources (59)
FDA (3670)
Job Trends (4011)
News (87126)
Policy (6613)
Tag
Academia (395)
Accelerated approval (14)
Adcomms (1)
Allergies (47)
Alliances (7391)
ALS (40)
Alzheimer's disease (605)
Antibody-drug conjugate (ADC) (94)
Approvals (3873)
Artificial intelligence (97)
Autoimmune disease (49)
Automation (10)
Bankruptcy (75)
Best Places to Work (3661)
BIOSECURE Act (2)
Biosimilars (36)
Biotechnology (27)
Bladder cancer (60)
Brain cancer (19)
Breast cancer (205)
Cancer (1517)
Cardiovascular disease (129)
Career advice (155)
Career pathing (4)
CAR-T (59)
CDC (10)
Cell therapy (149)
Cervical cancer (16)
Clinical research (17577)
Collaboration (282)
Compensation (218)
Complete response letters (12)
COVID-19 (492)
CRISPR (14)
C-suite (108)
Cystic fibrosis (38)
Data (2336)
Decentralized trials (1)
Depression (45)
Dermatology (17)
Diabetes (117)
Diagnostics (2112)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (37)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (79)
Earnings (42240)
Editorial (9)
Employer branding (10)
Employer resources (46)
Events (26681)
Executive appointments (132)
FDA (4757)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (226)
Gene editing (34)
Generative AI (8)
Gene therapy (119)
GLP-1 (294)
Government (863)
Grass and pollen (1)
Guidances (312)
Healthcare (5104)
HIV (17)
Huntington's disease (13)
IgA nephropathy (30)
Immunology and inflammation (42)
Immuno-oncology (14)
Indications (52)
Infectious disease (572)
Inflammatory bowel disease (45)
Inflation Reduction Act (2)
Influenza (40)
Intellectual property (59)
Interviews (17)
IPO (6786)
IRA (2)
Job creations (471)
Job search strategy (142)
JPM (5)
Kidney cancer (6)
Labor market (33)
Layoffs (117)
Leadership (3)
Legal (1242)
Liver cancer (29)
Longevity (5)
Lung cancer (225)
Lymphoma (146)
Machine learning (8)
Management (13)
Manufacturing (141)
MASH (57)
Medical device (4173)
Medtech (4189)
Mergers & acquisitions (4009)
Metabolic disorders (362)
mRNA (23)
Multiple sclerosis (39)
NASH (4)
Neurodegenerative disease (66)
Neuropsychiatric disorders (23)
Neuroscience (939)
NextGen: Class of 2026 (1097)
Non-profit (876)
Now hiring (16)
Obesity (179)
Opinion (52)
Ovarian cancer (44)
Pain (37)
Pancreatic cancer (62)
Parkinson's disease (77)
Partnered (5)
Patents (126)
Patient recruitment (92)
Peanut (18)
People (8396)
Pharmaceutical (8)
Pharmacy benefit managers (5)
Phase 1 (4922)
Phase 2 (7557)
Phase 3 (6657)
Pipeline (3026)
Policy (36)
Postmarket research (590)
Preclinical (1815)
Press Release (18)
Prostate cancer (71)
Psychedelics (7)
Radiopharmaceuticals (70)
Rare diseases (212)
Real estate (727)
Recruiting (21)
Regulatory (5666)
Reports (35)
Research institute (409)
Resumes & cover letters (19)
Rett syndrome (6)
RNA editing (1)
RSV (21)
Schizophrenia (59)
Series A (24)
Series B (25)
Service/supplier (3)
Sickle cell disease (20)
Special edition (13)
Spinal muscular atrophy (32)
Sponsored (7)
Startups (388)
Stomach cancer (1)
Supply chain (16)
Tariffs (33)
The Weekly (9)
Vaccines (193)
Venture capital (14)
Weight loss (122)
Women's health (19)
Worklife (3)
Date
Last 7 days (207)
Last 30 days (785)
Last 365 days (8838)
2026 (2259)
2025 (9140)
2024 (9883)
2023 (29235)
2022 (11831)
2021 (12920)
2020 (12516)
2019 (9478)
2018 (7086)
2017 (7113)
2016 (5619)
2015 (7724)
2014 (4869)
2013 (3289)
2012 (4053)
2011 (4397)
2010 (3710)
Location
Africa (124)
Alabama (21)
Alaska (2)
Arizona (78)
Arkansas (2)
Asia (9163)
Australia (1515)
California (3515)
Canada (850)
China (283)
Colorado (201)
Connecticut (209)
Delaware (153)
Europe (21790)
Florida (588)
Georgia (144)
Hawaii (1)
Idaho (14)
Illinois (307)
India (22)
Indiana (246)
Iowa (2)
Japan (120)
Kansas (70)
Kentucky (12)
Louisiana (15)
Maine (64)
Maryland (463)
Massachusetts (2326)
Michigan (107)
Minnesota (193)
Missouri (31)
Montana (9)
Nebraska (10)
Nevada (33)
New Hampshire (22)
New Jersey (1242)
New Mexico (7)
New York (1045)
North Carolina (428)
North Dakota (2)
Northern California (1832)
Ohio (98)
Oklahoma (4)
Oregon (10)
Pennsylvania (762)
Puerto Rico (7)
Rhode Island (12)
South America (219)
South Carolina (12)
Southern California (1399)
Tennessee (38)
Texas (561)
United States (13175)
Utah (108)
Virginia (72)
Washington D.C. (17)
Washington State (324)
West Virginia (1)
Wisconsin (27)
165,042 Results for "27".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Secretome Therapeutics Announces Participation in Upcoming Investor Conferences - March 27, 2026
March 27, 2026
·
1 min read
Layoffs
Lundbeck Offloads Assets to Three Partners as it Exits 27 Markets, Leaving 602 Jobless
These 27 markets, comprising countries across Asia, Europe and South America, together contributed some 12% of Lundbeck’s earnings in 2024.
September 10, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 27, 2026
March 30, 2026
·
2 min read
Press Releases
Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026
March 23, 2026
·
5 min read
Press Releases
CNS Pharmaceuticals Issues Letter to Shareholders - January 27, 2026
January 28, 2026
·
7 min read
Press Releases
Australian Breast Cancer Innovators Close $27M Private Funding Round
February 12, 2026
·
5 min read
Press Releases
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab - February 27, 2026
March 2, 2026
·
4 min read
Press Releases
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - January 27, 2026
January 28, 2026
·
1 min read
Press Releases
Zymeworks Announces Participation in Upcoming Investor Conferences - January 27, 2026
January 27, 2026
·
2 min read
Press Releases
Korro to Host Virtual Analyst Day on January 27, 2026
January 20, 2026
·
8 min read
1 of 16,505
Next
